What is PeproMene Bio worth?
$114.8Mlast known valuation
PeproMene Bio last raised $40.2M in its Early Stage VC (Jul 2017).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for PeproMene Bio
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2017 | Early Stage VC | $40.2M | ▮ | ▮ |
How PeproMene Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For PeproMene Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is PeproMene Bio worth?
- PeproMene Bio's last known valuation is $114.8M.
- How much has PeproMene Bio raised?
- PeproMene Bio has raised $50.2M in total funding across 1 recorded rounds.
- When did PeproMene Bio last raise?
- PeproMene Bio last raised in Jul 2017 (Early Stage VC), raising $40.2M.